NCT04230941: Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase I

NCT04230941
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER++, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Not yet recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 65 Years and older ¬† (Older Adult)
Location of Metastases: 
Additional Notes: 
Exclusions: Patients under the age of 65
https://ClinicalTrials.gov/show/NCT04230941

Comments are closed.

Up ↑